Altered Syncytin and ASCT2 Expressions in Preeclampsic Placenta and Hypoxia-Treated BeWo Cells Syncytialization

HU Rong,LI Xiao-tian,ZUO Ji
DOI: https://doi.org/10.3969/j.issn.1672-8467.2007.01.006
2007-01-01
Abstract:Purpose A human endogenous retroviral element,designated as syncytin,has been suggested as a contributor to the fusion processes of cytotrophoblasts to syncytiotrophoblasts.We tried to investigate the alterations of syncytin and its receptor ASCT2 expression in placental development and preeclampsia and hypoxia-treated BeWo cells syncytialization. Methods Real time PCR was used to study the syncytin and ASCT2 mRNA expression during placental development in 25 placentas from women without preeclampsia(ranged from 7-12,30-36 and 37-40 weeks of gestation).The levels of syncytin and ASCT2 mRNA expressions were tested in preeclamptic placentas(n=8) compared with gestational age-matched controls(n=8),and further studied in forskolin induced BeWo cells syncytialization under normanix or hypoxia. Results When compared with 7-12 weeks of gestation,the expression of syncytin mRNA increased significantly in 30-36 weeks of gestation,then it was reduced after 37 weeks of gestation.The ASCT2 mRNA expression was decreased significantly since 30 weeks of gestation and was relatively stable since then to 40 weeks of gestation.The expression of syncytin elevated,and that of ASCT2 reduced in forskolin induced BeWo cells fusion.Furthermore,a significant reduction in syncytin mRNA expression was observed in preeclamptic placenta and BeWo cells syncytialization under hypoxia,but no reduction in ASCT2 mRNA expression. Conclusions Syncytin and ASCT2 are involved in modulating cell fusion processes.Disturbed placental function in preeclampsia may be due to hypoxia-reduced expression of syncytin.
What problem does this paper attempt to address?